Grove Biopharma, Inc. | $30,000,000 | (Apr 25, 2025)
Northwood | $30,000,000 | (Apr 25, 2025)
Steadily Insurance Company | $30,000,000 | (Apr 25, 2025)
Epicore Biosystems
United States
- Cambridge, Massachusetts
- 09/02/2022
- Series A
- $10,000,000
Epicore Biosystems, Inc. has developed a proprietary sweat microfluidic sensing platform that is ‘skin-like’, low-cost, and capable of analyzing small droplets of sweat directly from the skin. This technology is based on over two decades of microfluidic and soft materials research in Prof. John Rogers' Laboratory at Northwestern University's Center for Bio-Integrated Electronics.
Epicore Biosystems recently signed a partnership with a leading Fortune 100 global brand to commercialize the first-ever, single-use sweat analytics system for athletes. The company’s sweat microfluidic platform has been deployed with professional sports teams (NBA, NFL, and MLB), military research labs, and across multiple clinical study programs, including stroke, skin health, stress, fatigue, and kidney health
- Industry Medical Equipment Manufacturing
- Website https://www.epicorebiosystems.com/
- LinkedIn https://www.linkedin.com/company/epicore-biosystems/
Alternative Payments | $22,000,000 | (Apr 25, 2025)
Listen Labs | $27,000,000 | (Apr 25, 2025)
Lace | $14,000,000 | (Apr 25, 2025)
RISE® Robotics | $1,500,000 | (Apr 25, 2025)
Ravenna | $15,000,000 | (Apr 25, 2025)
ChEmpower Corporation | $18,700,000 | (Apr 25, 2025)
Theo | $20,000,000 | (Apr 25, 2025)
Isembard | $9,000,000 | (Apr 25, 2025)
Electra(US) | $186,000,000 | (Apr 25, 2025)